Bio-Path Launches $4 Million Private Placement of Shares, Warrants; Shares Fall

MT Newswires Live10-09

Bio-Path Holdings (BPTH) said Wednesday it agreed to a $4 million private placement of common stock, series A warrants and short-term series B warrants.

The offering covers 4.6 million common shares, series A warrants to purchase 6.4 million shares and short-term series B warrants to purchase 6.4 million shares, and is priced at $0.87 per share and accompanying warrants, according to the company.

The warrants have an exercise price of $1 and can be exercised after shareholders approve the issuance of shares covered under the warrants, Bio-Path added.

The company said series A warrants and short-term series B warrants will expire five years and 24 months after the stockholder approval date, respectively.

The company expects to close the offering on Thursday and said net proceeds will be used for working capital and general corporate purposes.

Bio-Path's shares fell 17% in recent trading.

Price: 0.99, Change: -0.20, Percent Change: -16.97

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment